POULVAC LARYNGO SA2

Country: Аустралија

Језик: Енглески

Извор: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Активни састојак:

INFECTIOUS LARYNGOTRACHEITIS VIRUS STRAIN S.A.2; GENTAMICIN; NYSTATIN

Доступно од:

ZOETIS AUSTRALIA PTY LTD

INN (Међународно име):

vaccine - ILT

Фармацеутски облик:

MISC. VACCINES OR ANTI SERA

Састав:

INFECTIOUS LARYNGOTRACHEITIS VIRUS STRAIN S.A.2 VACCINE-VIRAL Active 0.0 P; GENTAMICIN ANTIBIOTIC Other 0.44 ug/do; NYSTATIN ANTIBIOTIC Other 0.44 units/do

Јединице у пакету:

!10 x 500; !Dose vial; #10 x 2000; #Dose vial; %10 x 750; %doses; *10 x 1000; *Dose vial; ^10 x 1500; ^doses; 1000 Doses; 2000 D

Класа:

VM - Veterinary Medicine

Произведен од:

ZOETIS AUSTRALIA

Терапеутска група:

POULTRY | BREEDERS | BROILER | CHICKENS | CHICKS | CHOOKS | DAY OLD CHICKS | HATCHLINGS | LAYERS

Терапеутска област:

IMMUNOTHERAPY

Терапеутске индикације:

INFECTIOUS LARYNGOTRACHEITIS | GALLID HERPESVIRUS 1 | ILT

Резиме производа:

Poison schedule: 0; Withholding period: WHP:NIL; Host/pest details: POULTRY: [INFECTIOUS LARYNGOTRACHEITIS]; Poison schedule: 0; Withholding period: ; Host/pest details: POULTRY: [INFECTIOUS LARYNGOTRACHEITIS]; For the prevention of infectious laryngotracheitis in poultry.See WARNING STATEMENT on ILTV vaccine viruses.

Статус ауторизације:

Registered

Датум одобрења:

2023-07-01

Информативни летак

COMPANY NAME:
PRODUCT NAME:
PRODUCT NO:
ZOETIS AUSTRALIA PTY LTD
POULVAC LARYNGO SA2
50573/101106
LABEL NAME:
POULVAC LARYNGO SA2
SIGNAL HEADINGS:
FOR ANIMAL TREATMENT ONLY
CONSTITUENT
STATEMENTS:
Infectious laryngotracheitis virus (SA2 strain;
≥
10^4.1pfu)
Gentamicin (0.44 µg ) and Nystatin (0.44 units) added as
preservatives.
CLAIMS:
For the prevention of infectious laryngotracheitis in poultry
NET CONTENTS:
10 x 500 doses
10 x 750 doses
10 x 1000 doses
10 x 1500 doses
10 x 2000 doses
DIRECTIONS FOR USE:
Before Reconstitution
The vaccine will remain potent until the expiry date if stored below
–5°C (freeze).
Reconstituted Vaccine
• Once reconstituted, the vaccine must be used immediately.
• Special precautions should be taken to avoid heat and light damage
to the vaccine during
use.
• If ambient temperatures are expected to be high, small volumes of
vaccine should be
reconstituted and used quickly.
• Covered insulated containers containing ice should be used for the
movement of vaccine
vials from the main storage area to areas of use around the farm.
RESTRAINTS:
CONTRAINDICATIONS:
PRECAUTIONS:
1. Simultaneous administration of Poulvac Laryngo SA2 and Infectious
Bronchitis vaccines
is not recommended. RLP APPROVED
For Official Use Only
2. Only birds in good health should be vaccinated. The presence of
either concurrent
infections (e.g. mycoplasmosis, coryza) or husbandry stress factors
may cause a reaction.
3. The use of disinfectants or antiseptics in or on any equipment used
for the preparation of
Poulvac Laryngo SA2 must be avoided.
4. Sanitising chemicals in the farm water supply should not be used
for 3 days prior to
vaccination with Poulvac Laryngo SA2.
5. All recommendations on the storage and care of the unreconstituted
vaccine must be
followed.
6. Reconstituted vaccine must be prepared, stored and transported as
recommended. It
must be used immediately after reconstitution.
7. ALL BIRDS MUST RECEIVE THE FULL DOSE OF LIVING VACCINE TO BE FULLY
PROTECTED.
Please note that management conditio

Карактеристике производа

PRODUCT NAME: POULVAC LARYNGO SA2
PAGE: 1 OF 5
THIS REVISION ISSUED: APRIL, 2013
SAFETY DATA SHEET
Issued by: Pfizer Animal Health Australia Pty Ltd
Phone: [phone]
POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800
764 766 IN NEW ZEALAND)
SECTION 1 - IDENTIFICATION OF THE MATERIAL AND SUPPLIER
Pfizer Animal Health Australia Pty Ltd
38-42 Wharf Road
West Ryde NSW 2114
Tel: [phone]
Fax: [phone]
__________________________________________________________
PFIZER ANIMAL HEALTH AUSTRALIA PTY LTD
ABN 94 156 476 425
CHEMICAL NATURE:
Live avian virus freeze dried for reconstitution and use.
TRADE NAME:
POULVAC LARYNGO SA2
APVMA CODE:
50573
PRODUCT USE:
Vaccine for prevention of infectious laryngotracheitis in poultry.
CREATION DATE:
APRIL, 2013
THIS VERSION ISSUED:
APRIL, 2013
and is valid for 5 years from this date.
SECTION 2 - HAZARDS IDENTIFICATION
STATEMENT OF HAZARDOUS NATURE
This product is classified as:
Not classified as hazardous according to the criteria of SWA.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
S22, S25, S36. Do not breathe dust. Avoid contact with eyes. Wear
suitable protective clothing.
SUSMP CLASSIFICATION:
None allocated.
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
GHS SIGNAL WORD: NONE. NOT HAZARDOUS.
PREVENTION
P102: Keep out of reach of children.
P235: Keep cool.
RESPONSE
P353: Rinse skin or shower with water.
P301+P330+P331: IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P332+P313: If skin irritation occurs: Get medical advice.
P337+P313: If eye irritation persists: Get medical advice.
P370+P378: Not combustible. Use extinguishing media suited to burning
materials.
STORAGE
P401: Store at -5°C in the closed original container.
DISPOSAL
P501: Dispose of small quantities and empty containers by wrapping
with paper and putting in garbage. For
larger quantities, if recycling or reclaiming is not possible,